146 related articles for article (PubMed ID: 25297533)
1. Compound lesion of a basal cell carcinoma and a malignant melanoma: is there a common genetic origin?
Sharma SJ; Kreisel M; Holler C; Kroll T; Gamerdinger U; Gattenloehner S; Klussmann JP; Wittekindt C
Eur Arch Otorhinolaryngol; 2015 Feb; 272(2):505-9. PubMed ID: 25297533
[No Abstract] [Full Text] [Related]
2. Pigmented basal cell carcinoma and superficial spreading malignant melanoma: an unusual combination.
Bhawan J; Mehregan AH; Jung-Legg Y; Gellis SE
J Cutan Pathol; 1984 Dec; 11(6):471-5. PubMed ID: 6520255
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and BRCA2 families and the risk of skin cancer.
Ginsburg OM; Kim-Sing C; Foulkes WD; Ghadirian P; Lynch HT; Sun P; Narod SA;
Fam Cancer; 2010 Dec; 9(4):489-93. PubMed ID: 20809262
[TBL] [Abstract][Full Text] [Related]
4. Unscheduled Visits of Patients with Familial Melanoma to a Pigmented Lesion Clinic: Evaluation of Patients' Characteristics and Suspicious Lesions.
Nabil R; Plasmeijer E; van Doorn R; Bergman W; Kukutsch NA
Acta Derm Venereol; 2018 Jul; 98(7):667-670. PubMed ID: 29542807
[TBL] [Abstract][Full Text] [Related]
5. Update on familial cancer syndromes and the skin.
Tsao H
J Am Acad Dermatol; 2000 Jun; 42(6):939-69; quiz 970-2. PubMed ID: 10827397
[TBL] [Abstract][Full Text] [Related]
6. Lepromatous leprosy, melanoma, and basal cell carcinoma: clinical-histopathologic association.
Braghiroli CS; Parise-Fortes MR; Marques MEA; Lastória JC
An Bras Dermatol; 2019; 94(5):586-589. PubMed ID: 31777361
[TBL] [Abstract][Full Text] [Related]
7. Does having basal cell carcinoma increase a person's risk of melanoma?
Strayer SM
Health News; 2003 Aug; 9(8):12. PubMed ID: 12971322
[No Abstract] [Full Text] [Related]
8. Molecular biology of malignant melanoma and other cutaneous tumors.
Pons M; Quintanilla M
Clin Transl Oncol; 2006 Jul; 8(7):466-74. PubMed ID: 16870533
[TBL] [Abstract][Full Text] [Related]
9. BRCA1-Associated Protein-1 Tumor Predisposition Syndrome in a Patient With Numerous Basal Cell Carcinomas.
Ren V; Bloomquist L; Orengo I; Rosen T
Dermatol Surg; 2019 Feb; 45(2):316-318. PubMed ID: 29757857
[No Abstract] [Full Text] [Related]
10. A comparative study of gene-expression data of basal cell carcinoma and melanoma reveals new insights about the two cancers.
Xu K; Mao X; Mehta M; Cui J; Zhang C; Xu Y
PLoS One; 2012; 7(1):e30750. PubMed ID: 22295108
[TBL] [Abstract][Full Text] [Related]
11. TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Griewank KG; Murali R; Schilling B; Schimming T; Möller I; Moll I; Schwamborn M; Sucker A; Zimmer L; Schadendorf D; Hillen U
PLoS One; 2013; 8(11):e80354. PubMed ID: 24260374
[TBL] [Abstract][Full Text] [Related]
12. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
13. Collision tumor of cutaneous malignant melanoma and basal cell carcinoma.
Hirakawa E; Miki H; Kobayashi S; Nomura Y; Ohmori M
Pathol Res Pract; 1998; 194(9):649-53. PubMed ID: 9793966
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetics of melanoma and nonmelanoma skin cancer.
Carless MA; Griffiths LR
Adv Exp Med Biol; 2014; 810():160-81. PubMed ID: 25207365
[TBL] [Abstract][Full Text] [Related]
15. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
[TBL] [Abstract][Full Text] [Related]
16. Melanocortin-1 receptor: loss of function mutations and skin cancer.
Mumm CD; Draznin M
Dermatol Online J; 2006 Sep; 12(5):13. PubMed ID: 16962028
[TBL] [Abstract][Full Text] [Related]
17. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.
Gudbjartsson DF; Sulem P; Stacey SN; Goldstein AM; Rafnar T; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Sveinsdottir SG; Magnusson V; Lindblom A; Kostulas K; Botella-Estrada R; Soriano V; Juberías P; Grasa M; Saez B; Andres R; Scherer D; Rudnai P; Gurzau E; Koppova K; Kiemeney LA; Jakobsdottir M; Steinberg S; Helgason A; Gretarsdottir S; Tucker MA; Mayordomo JI; Nagore E; Kumar R; Hansson J; Olafsson JH; Gulcher J; Kong A; Thorsteinsdottir U; Stefansson K
Nat Genet; 2008 Jul; 40(7):886-91. PubMed ID: 18488027
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
19. Melanoma susceptibility variants on chromosome 20q11.22 are associated with pigmentary traits and the risk of nonmelanoma skin cancer.
Nan H; Qureshi AA; Han J
Br J Dermatol; 2010 Feb; 162(2):461-3. PubMed ID: 19995372
[No Abstract] [Full Text] [Related]
20. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?
Dwyer T; Stankovich JM; Blizzard L; FitzGerald LM; Dickinson JL; Reilly A; Williamson J; Ashbolt R; Berwick M; Sale MM
Am J Epidemiol; 2004 May; 159(9):826-33. PubMed ID: 15105175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
